Correlation Between Knight Therapeutics and IShares Canadian

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Knight Therapeutics and IShares Canadian at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Knight Therapeutics and IShares Canadian into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Knight Therapeutics and iShares Canadian HYBrid, you can compare the effects of market volatilities on Knight Therapeutics and IShares Canadian and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Knight Therapeutics with a short position of IShares Canadian. Check out your portfolio center. Please also check ongoing floating volatility patterns of Knight Therapeutics and IShares Canadian.

Diversification Opportunities for Knight Therapeutics and IShares Canadian

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Knight and IShares is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Knight Therapeutics and iShares Canadian HYBrid in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Canadian HYBrid and Knight Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Knight Therapeutics are associated (or correlated) with IShares Canadian. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Canadian HYBrid has no effect on the direction of Knight Therapeutics i.e., Knight Therapeutics and IShares Canadian go up and down completely randomly.

Pair Corralation between Knight Therapeutics and IShares Canadian

Assuming the 90 days trading horizon Knight Therapeutics is expected to under-perform the IShares Canadian. In addition to that, Knight Therapeutics is 6.71 times more volatile than iShares Canadian HYBrid. It trades about -0.01 of its total potential returns per unit of risk. iShares Canadian HYBrid is currently generating about 0.2 per unit of volatility. If you would invest  1,857  in iShares Canadian HYBrid on October 7, 2024 and sell it today you would earn a total of  126.00  from holding iShares Canadian HYBrid or generate 6.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Knight Therapeutics  vs.  iShares Canadian HYBrid

 Performance 
       Timeline  
Knight Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Knight Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
iShares Canadian HYBrid 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in iShares Canadian HYBrid are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy fundamental drivers, IShares Canadian is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Knight Therapeutics and IShares Canadian Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Knight Therapeutics and IShares Canadian

The main advantage of trading using opposite Knight Therapeutics and IShares Canadian positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Knight Therapeutics position performs unexpectedly, IShares Canadian can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Canadian will offset losses from the drop in IShares Canadian's long position.
The idea behind Knight Therapeutics and iShares Canadian HYBrid pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk